Dysregulation of miR-15a and miR-214 in human pancreatic cancer

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Zhang, Xing J ^a   Ye, Hua ^b   Zeng, Cheng W ^a   He, Bo ^b   Zhang, Hua ^a   Chen, Yue Q ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; KERATINOCYTE GROWTH FACTOR; MICRORNA; MICRORNA 15A; MICRORNA 214; UNCLASSIFIED DRUG; WNT3A PROTEIN; MIRN15 MICRORNA, HUMAN; MIRN214 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER TISSUE; CELL VIABILITY; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; PANCREAS CANCER; UPREGULATION; BIOSYNTHESIS; CELL GROWTH; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY;

APOPTOSIS; CELL GROWTH PROCESSES; CELL SURVIVAL; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS;

EID: 78549293104     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-46     Document Type: Article

References (33)

1. Cancer of the uncinate process of the pancreas: surgical anatomy and clinicopathological features. AW O'Sullivan N Heaton M Rela, Hepatobiliary Pancreat Dis Int 2009 8 6 569 74 20007071
2. Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions. R Andersson U Aho BI Nilsson GJ Peters M Pastor-Anglada W Rasch ML Sandvold, Scand J Gastroenterol 2009 44 7 782 6 10.1080/ 00365520902745039 19214867
3. Identification of novel genes coding for small expressed RNAs. M Lagos-Quintana R Rauhut W Lendeckel T Tuschl, Science 2001 294 5543 853 8 10.1126/science.1064921 11679670
4. Oncomirs - microRNAs with a role in cancer. A Esquela-Kerscher FJ Slack, Nat Rev Cancer 2006 6 4 259 69 10.1038/nrc1840 16557279
5. A microRNA expression signature of human solid tumors defines cancer gene targets. S Volinia GA Calin CG Liu S Ambs A Cimmino F Petrocca R Visone M Iorio C Roldo M Ferracin RL Prueitt N Yanaihara G Lanza A Scarpa A Vecchione M Negrini CC Harris CM Croce, Proc Natl Acad Sci USA 2006 103 7 2257 61 10.1073/pnas.0510565103 16461460
6. The Clinical Potential of MicroRNAs. A Budhu JF Ji XW Wang, Journal of Hematology & Oncology 2010 3 37
7. MicroRNA expression profiles classify human cancers. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando JR Downing T Jacks HR Horvitz TR Golub, Nature 2005 435 7043 834 8 10.1038/nature03702 15944708
8. MicroRNAs accurately identify cancer tissue origin. N Rosenfeld R Aharonov E Meiri S,, et al. Nat Biotechnol 2008 26 4 462 9 10.1038/nbt1392 18362881
9. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. N Habbe JB Koorstra JT Mendell GJ Offerhaus JK Ryu G Feldmann ME Mullendore MG Goggins SM Hong A Maitra, Cancer Biol Ther 2009 8 4 340 6 19106647
10. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. M Dillhoff J Liu W Frankel C Croce M Bloomston, J Gastrointest Surg 2008 12 12 2171 6 10.1007/s11605-008-0584-x 18642050
11. MicroRNAs linked to pancreatic cancer. T Hampton, JAMA 2007 297 9 937 10.1001/jama.297.9.937 17341695
12. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. M Bloomston WL Frankel F Petrocca S Volinia H Alder JP Hagan CG Liu D Bhatt C Taccioli CM Croce, JAMA 2007 297 17 1901 8 10.1001/jama.297.17.1901 17473300
13. Expression profiling identifies microRNA signature in pancreatic cancer. EJ Lee Y Gusev J Jiang GJ Nuovo MR Lerner WL Frankel DL Morgan RG Postier DJ Brackett TD Schmittgen, Int J Cancer 2007 120 5 1046 54 10.1002/ijc.22394 17149698
14. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. FC Lynn P Skewes-Cox Y Kosaka MT McManus BD Harfe MS German, Diabetes 2007 56 12 2938 45 10.2337/db07-0175 17804764
15. miR-15 and miR-16 induce apoptosis by targeting BCL2. A Cimmino GA Calin M Fabbri MV Iorio M Ferracin M Shimizu SE Wojcik RI Aqeilan S Zupo M Dono L Rassenti H Alder S Volinia CG Liu TJ Kipps M Negrini CM Croce, Proc Natl Acad Sci USA 2005 102 39 13944 9 10.1073/pnas.0506654102 16166262
16. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. D Bonci V Coppola M Musumeci A Addario R Giuffrida L Memeo L D'Urso A Pagliuca M Biffoni C Labbaye M Bartucci G Muto C Peschle R De Maria, Nat Med 2008 14 11 1271 7 10.1038/nm.1880 18931683
17. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. N Bandi S Zbinden M Gugger M Arnold V Kocher L Hasan A Kappeler T Brunner E Vassella, Cancer Res 2009 69 13 5553 9 10.1158/0008-5472. CAN-08-4277 19549910
18. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. R Bhattacharya M Nicoloso R Arvizo E Wang A Cortez S Rossi GA Calin P Mukherjee, Cancer Res 2009 69 23 9090 5 10.1158/0008-5472.CAN-09-2552 19903841
19. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. Z Yang S Chen X Luan Y Li M Liu X Li T Liu H Tang, IUBMB Life 2009 61 11 1075 82 10.1002/iub.252 19859982
20. Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. PT Jindra J Bagley JG Godwin J Iacomini, J Immunol 185 2 990 7 10.4049/jimmunol.1000793 20548023
21. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. H Yang W Kong L He JJ Zhao JD O'Donnell J Wang RM Wenham D Coppola PA Kruk SV Nicosia JQ Cheng, Cancer Res 2008 68 2 425 33 10.1158/0008-5472.CAN-07-2488 18199536
22. Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience. G Tuinmann S Hegewisch-Becker R Zschaber A Kehr J Schulz DK Hossfeld, Anticancer Drugs 2004 15 6 575 9 10.1097/01.cad.0000131683. 29260.d1 15205599
23. Cytotoxic therapy for advanced pancreatic adenocarcinoma. EM O'Reilly GK Abou-Alfa, Semin Oncol 2007 34 4 347 53 10.1053/j.seminoncol.2007.05.009 17674963
24. Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions. HQ Xiong K Carr JL Abbruzzese, Drugs 2006 66 8 1059 72 10.2165/00003495-200666080-00003 16789792
25. Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines. W Huanwen L Zhiyong S Xiaohua R Xinyu W Kai L Tonghua, Mol Cancer 2009 8 125 10.1186/1476-4598-8-125 20021699
26. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. S Nomura H Yoshitomi S Takano T Shida S Kobayashi M Ohtsuka F Kimura H Shimizu H Yoshidome A Kato M Miyazaki, Br J Cancer 2008 99 2 305 13 10.1038/sj.bjc.6604473 18594526
27. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. I Garkavtsev SV Kozin O Chernova L Xu F Winkler E Brown GH Barnett RK Jain, Nature 2004 428 6980 328 32 10.1038/nature02329 15029197
28. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. S Kim K Chin JW Gray JM Bishop, Proc Natl Acad Sci USA 2004 101 46 16251 6 10.1073/pnas.0407158101 15528276
29. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. F Fang LB Luo YM Tao F Wu LY Yang, Cancer Epidemiol Biomarkers Prev 2009 18 2 409 16 10.1158/1055-9965.EPI-08-0575 19208663
30. Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Y Xie H Zhang W Sheng J Xiang Z Ye J Yang, Cancer Lett 2008 271 1 105 16 10.1016/j.canlet.2008.05.050 18789575
31. MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. X Zhang W Zhu J Zhang S Huo L Zhou Z Gu M Zhang, Biochem Biophys Res Commun 395 2 275 80 10.1016/j.bbrc.2010.04.005 20381459
32. Real-time quantification of microRNAs by stem-loop RT-PCR. C Chen DA Ridzon AJ Broomer Z Zhou DH Lee JT Nguyen M Barbisin NL Xu VR Mahuvakar MR Andersen KQ Lao KJ Livak KJ Guegler, Nucleic Acids Res 2005 33 20 179 10.1093/nar/gni178 16314309
33. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 4 402 8 10.1006/meth.2001.1262 11846609